{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Anjali Arora"}, {"accession": "MS:1000589", "name": "contact email", "value": "anjaliarora@iisc.ac.in"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Research Associate"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Prof. Kumaraval Somasundaram"}, {"accession": "MS:1000589", "name": "contact email", "value": "skumar1@iisc.ac.in"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Professor at Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India"}]}], "datasetFiles": [{"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD012207/iTRAQ_F01.RAW"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD012207/iTRAQ_F02.RAW"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD012207/iTRAQ_F03.RAW"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD012207/iTRAQ_F04.RAW"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD012207/iTRAQ_F05.RAW"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD012207/iTRAQ_F06.RAW"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD012207/iTRAQ_F07.RAW"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD012207/iTRAQ_F08.RAW"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD012207/iTRAQ_F09.RAW"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD012207/iTRAQ_F10.RAW"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD012207/iTRAQ_F11.RAW"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD012207/iTRAQ_F12.RAW"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD012207/iTRAQ_Merged_MS.msf"}], "description": "Glioblastoma (GBM) is the most aggressive form of astrocytoma and is difficult to diagnose at early stage. In this study, our goal is to find and validate biomarkers for GBM through serum proteome expression profiling, which would assist in the early diagnosis, and management of GBMs. In the discovery phase, we performed shotgun proteomics of control and GBM pooled serum samples using untargeted 4-plex iTRAQ (isobaric Tags for Relative and Absolute Quantitation) mass spectrometry to identify candidate biomarkers with differential abundance The two candidates, S100A8 and S100A9 were prioritized for verification based on their maximal abundance in GBM serum in our discovery phase.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/03/PXD012207"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD012207"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD012207"}], "instruments": [{"accession": "MS:1000556", "name": "LTQ Orbitrap XL"}, {"accession": "MS:1001910", "name": "LTQ Orbitrap Elite"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Human, Serum, iTRAQ, glioblastoma, GBM"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}], "modifications": [{"accession": "MOD:01499", "name": "iTRAQ4plex-116 reporter+balance reagent acylated residue"}, {"accession": "MOD:00696", "name": "phosphorylated residue"}, {"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00394", "name": "acetylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}, {"accession": "MOD:00400", "name": "deamidated residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "30808902"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Arora A, Patil V, Kundu P, Kondaiah P, Hegde AS, Arivazhagan A, Santosh V, Pal D, Somasundaram K. Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma. Sci Rep. 2019 9(1):2749"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Glioblastoma  serum biomarkers identification by iTRAQ"}